Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC 1,4-Oxazepin-5(2H)-one, 4-[3-[[2-[[2-ethyl-4-(4-methyl-1-piperazinyl)phenyl)amino]-5-... | 2543673-19-2 | 99.7% | 535.60 | 1 G
SDP

Supplier:  Medchemexpress LLC HY1606991G

Encompass_Preferred

DCC-3116 is an orally active ULK1/2 inhibitor. It inhibits autophagy in lung cancer cells by targeting KRASG12C signaling, which in turn reduces the proliferation of lung cancer cells and exerts anti-cancer effects.

  • Orally active ULK1/2 inhibitor
  • Inhibits autophagy in lung cancer cells
  • Targets KRASG12C signaling
  • Reduces proliferation of lung cancer cells
  • Exerts anti-cancer effects

Catalog No. 50-003-94573


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.